Journal of Diabetes Research

Molecular and Imaging Biomarkers and Artificial Intelligence in Diabetic Retinopathy


Publishing date
01 Jan 2022
Status
Closed
Submission deadline
03 Sep 2021

Lead Editor

1Guangdong Provincial People's Hospital, Guangzhou, China

2The First Affiliated Hospital of China Medical University, Shenyang, China

3Aier School of Ophthalmology, Changsha, China

4Sun Yat-sen University, Guangzhou, China

5Central South University, Changsha, China

6University of Melbourne, Melbourne, Australia

This issue is now closed for submissions.

Molecular and Imaging Biomarkers and Artificial Intelligence in Diabetic Retinopathy

This issue is now closed for submissions.

Description

Diabetes mellitus (DM) is a major systemic disorder, imposing a huge global social-economical burden. Ocular complications such as diabetic retinopathy (DR) are common in DM patients, which can lead to severe visual impairment. Early diagnosis and proper management of DR is important for preventing visual impairment in DM patients. There is an urgent need for indicators to predict the occurrence, progression, and treatment outcomes of DR. DR biomarkers – both imaging and molecular – may reshape our understanding of the pathogenesis of the disease and are also particularly useful for early detection and prognosis prediction of DR. Although some imaging and molecular biomarkers of DR have been proposed, the journey of finding new and better biomarkers will continue.

In recent years, artificial intelligence (AI) has been implemented into the management of ocular diseases. AI techniques are capable of accurate diagnosis and outcome prediction and can be used to explore imaging and molecular biomarkers of DR, in addition to helping refine DR management strategies.

In this Special Issue, original research and review articles about imaging and molecular biomarkers and AI in DR are welcome. We aim to summarize the latest advancements in clinical studies or reviews on imaging and molecular biomarkers related to the diagnosis, progression, and treatment outcomes of DR, and the application of AI techniques in clinical research in DR.

Potential topics include but are not limited to the following:

  • Systemic and ocular molecular biomarkers of DR in biological samples, such as blood, intraocular fluid, or tears
  • Multimodal retinal imaging biomarkers of DR
  • Optical coherence tomography/optical coherence tomography angiography in the diagnosis and management of DR
  • Correlation and interaction between imaging and molecular biomarkers of DR
  • Application of AI techniques, such as machine learning and deep learning, in automated screening/diagnosis/prognosis prediction of DR
  • Exploration of DR biomarkers using AI techniques and big data analysis
Journal of Diabetes Research
 Journal metrics
See full report
Acceptance rate10%
Submission to final decision119 days
Acceptance to publication19 days
CiteScore7.100
Journal Citation Indicator0.760
Impact Factor4.3
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.